See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

Synlogic Adds $5M In Latest Round

Synlogic, a year-old, Boston-based next-generation synthetic biology company that's developing microbes as therapeutics, has added $5 million to a $29.4 million Series A round that the company closed earlier this year.


More from